Physician profile
Robert D Swift
NPI 1669448403
$22,053.29
in general payments reported to CMS, 2019-2025
22 companies · $779 in 2025
The $779 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,300 · 2020: $2,736 · 2021: $3,630 · 2022: $4,606 · 2023: $1,606 · 2024: $2,396 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,769 · Travel and Lodging: $2,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,768.67 |
| Travel and Lodging | $2,012.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $8,291.88 | 2020-2025 | Distal Extremities Implants Trauma Suture Plate |
| Trice Medical, INC. | $4,243.49 | 2019 | |
| Pinnacle, INC | $2,214.58 | 2019-2021 | |
| Acelrx Pharmaceuticals, INC. | $2,000.00 | 2021 | |
| Si-Bone, INC. | $1,857.83 | 2022-2025 | |
| Stryker Corporation | $993.83 | 2020-2025 | Mako, Aequalis Ascend Flex, Aequalis Flex Revive |
| Globus Medical, INC. | $678.31 | 2023-2025 | Legacy Stelkast Knee, Harvest |
| Depuy Synthes Sales INC. | $352.35 | 2023-2024 | Actis, Fibergraft Bg Morsels, Quickanchor Orthocord |
| Carbofix Orthopedics INC | $347.44 | 2023-2024 | |
| Linvatec Corporation | $254.31 | 2021-2024 | Biobrace 23mm |
| Zimmer Biomet Holdings, INC. | $239.62 | 2021-2023 | Rosa |
| Acera Surgical, INC. | $146.57 | 2024 | Restrata Wound Matrix |
| Anika Therapeutics, INC. | $124.81 | 2020-2021 | |
| Terumo Bct, INC. | $63.89 | 2022 | |
| Orthofix Medical, INC. | $59.74 | 2022-2023 | Physio-Stim |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $53.23 | 2019-2023 | Iovera, Exparel, Zilretta |
| Smith+Nephew, INC. | $35.35 | 2021 | |
| Solventum Corporation | $25.41 | 2025 | Prevena |
| Exactech, INC. | $19.91 | 2021 | |
| Heraeus Medical, LLC. | $19.25 | 2024 | |
| Ibsa Pharma INC. | $18.62 | 2023 | Tirosint, Licart |
| Fidia Pharma USA INC. | $12.87 | 2023 | Triluron, Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Swift listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.